Showing results (31-40 of 129) with videos related to
Sort By:
Pageof 13
Future Medicinal Chemistry|February 18, 2010
mGluR4-positive allosteric modulation as potential treatment for Parkinson's diseaseCorey R Hopkins, Craig W Lindsley, Colleen M NiswenderNeurobiology of Disease|September 7, 2016
Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonistsIrene Sebastianutto, Natallia Maslava, Corey R Hopkins, et al.Chemmedchem|May 29, 2025
Synthesis and Biological Characterization of 4,4-Difluoro-3-(phenoxymethyl)piperidine Scaffold as Dopamine 4 Receptor (D<sub>4</sub>R) Antagonist in vitro Tool compoundsSaeedeh Saeedi, Sumaiya Nahid, Anish K Vadukoot, et al.Plos One|August 1, 2012
DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cellsAda Ao, Jijun Hao, Corey R Hopkins, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2022
Discovery and characterization of benzyloxy piperidine based dopamine 4 receptor antagonistsKirsten T Tolentino, Viktoriya Mashinson, Anish K Vadukoot, et al.Current Topics in Medicinal Chemistry|September 17, 2009
Recent progress in the development of mGluR4 positive allosteric modulators for the treatment of Parkinson's diseaseCraig W Lindsley, Colleen M Niswender, Darren W Engers, et al.Insects|November 18, 2018
Pharmacological Inhibition of Inward Rectifier Potassium Channels Induces Lethality in Larval <i>Aedes aegypti</i>Renata Rusconi Trigueros, Corey R Hopkins, Jerod S Denton, et al.ACS Chemical Neuroscience|August 4, 2012
Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeuticsAlbert J Robichaud, Darren W Engers, Craig W Lindsley, et al.Bioorganic & Medicinal Chemistry Letters|December 13, 2018
Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903Swagat H Sharma, Juan Lorenzo Pablo, Monica Suarez Montesinos, et al.Bioorganic & Medicinal Chemistry Letters|May 4, 2013
Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probeDarren W Engers, Audrey Y Frist, Craig W Lindsley, et al.Pageof 13